GlassScriptPhysician profile
Alexander Michael Shannon
NPI 1003475765
$2,082.62
in general payments reported to CMS, 2019-2025
16 companies · $419 in 2025
The $419 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $17.36 · 2021: $15.48 · 2022: $486 · 2023: $554 · 2024: $416 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,389.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $435.18 | 2024-2025 | Cvac Aspiration System |
| Teleflex LLC | $374.11 | 2022-2024 | Urolift |
| Olympus America INC. | $293.77 | 2022-2024 | Itind System |
| Procept Biorobotics Corporation | $222.07 | 2019-2025 | |
| Medtronic, INC. | $179.03 | 2022-2024 | Interstim |
| Heron Therapeutics, INC. | $98.24 | 2023 | Zynrelef |
| Progenics Pharmaceuticals, INC. | $97.02 | 2023 | Pylarify |
| Axonics, INC. | $95.78 | 2022 | |
| Cook Medical LLC | $87.14 | 2022 | |
| Telix Pharmaceuticals | $82.65 | 2023 | Illuccix |
| Allergan, INC. | $40.54 | 2019 | |
| Boston Scientific Corporation | $17.36 | 2020 | |
| Ferring Pharmaceuticals INC. | $16.73 | 2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $15.48 | 2021 | |
| Pfizer INC. | $14.39 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $13.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Shannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.